Abstract
Identification of active ligands using computational methods is a challenging task. For example, molecular docking, pharmacophore modeling, and three dimensional quantitative structure-activity relationship models (3D-QSAR) are widely used methods to identify novel small molecules. However, all these methods have, in addition to advantages, also significant pitfalls. The aim of this study was to compare some commonly used computational methods to estimate their ability to separate highly active PDE4B-inhibitors from less active and inactive ones. Here, 152 molecules with pIC50-range of 3.4-10.5, originating from six original studies were used. High correlation coefficients by using docking, docking with postprocessing with molecular mechanics-generalized Born-surface area -method (MMGBSA), pharmacophore modeling, and 3D-QSAR were obtained. These results are well in line with earlier studies done with similar methods, and suggest that computational methods could be successfully used to identify novel PDE4B-inhibitors, especially if using multiple methods together.
Keywords: Molecular docking, molecular mechanics-generalized born-surface area, pharmacophore modeling, phosphodiesterase, three-dimensional quantitative structure-activity relationship, virtual screening.
Current Drug Discovery Technologies
Title:Reliability of Virtual Screening Methods in Prediction of PDE4Binhibitor Activity
Volume: 12 Issue: 2
Author(s): Victoria Shubina, Sanna Niinivehmas and Olli T. Pentikainen
Affiliation:
Keywords: Molecular docking, molecular mechanics-generalized born-surface area, pharmacophore modeling, phosphodiesterase, three-dimensional quantitative structure-activity relationship, virtual screening.
Abstract: Identification of active ligands using computational methods is a challenging task. For example, molecular docking, pharmacophore modeling, and three dimensional quantitative structure-activity relationship models (3D-QSAR) are widely used methods to identify novel small molecules. However, all these methods have, in addition to advantages, also significant pitfalls. The aim of this study was to compare some commonly used computational methods to estimate their ability to separate highly active PDE4B-inhibitors from less active and inactive ones. Here, 152 molecules with pIC50-range of 3.4-10.5, originating from six original studies were used. High correlation coefficients by using docking, docking with postprocessing with molecular mechanics-generalized Born-surface area -method (MMGBSA), pharmacophore modeling, and 3D-QSAR were obtained. These results are well in line with earlier studies done with similar methods, and suggest that computational methods could be successfully used to identify novel PDE4B-inhibitors, especially if using multiple methods together.
Export Options
About this article
Cite this article as:
Shubina Victoria, Niinivehmas Sanna and Pentikainen T. Olli, Reliability of Virtual Screening Methods in Prediction of PDE4Binhibitor Activity, Current Drug Discovery Technologies 2015; 12 (2) . https://dx.doi.org/10.2174/1570163812666150702123018
DOI https://dx.doi.org/10.2174/1570163812666150702123018 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Spondyloarthritis in Asian Countries – An Overview
Current Rheumatology Reviews TNF as a Target of Inflammation in Rheumatoid Arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
Current Molecular Medicine The Two Faces of Interleukin-17A in Atherosclerosis
Current Drug Targets Transient Receptor Potential Vanilloid 1 Channel Modulation: A Novel Approach to Pain Therapy
Current Bioactive Compounds Methotrexate Induced Pneumonitis: A Review Article
Current Respiratory Medicine Reviews Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Regenerative Medicine Recent Advances in Psoriasis Therapy: Trends and Future Prospects
Current Drug Targets In Vivo Target Validation: Methodology and Case Studies on the Janus Kinase Tyk2
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Metabolomics as a Tool for Drug Discovery and Personalised Medicine. A Review
Current Topics in Medicinal Chemistry Leukocyte-Endothelial Cell Interactions: A Therapeutic Target to Ameliorate Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents IL-27: Friend or Foe in the Autoimmune Diseases
Current Immunology Reviews (Discontinued) Cardiovascular Involvement in Pediatric Systemic Autoimmune Diseases: The Emerging Role of Noninvasive Cardiovascular Imaging
Inflammation & Allergy - Drug Targets (Discontinued) MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Cutaneous Markers of HIV Infection and Progression
Current HIV Research Diagnosis of Gout: Considering Clinical and Research Settings
Current Rheumatology Reviews Lipid Nanoparticles and their Application in Nanomedicine
Current Pharmaceutical Biotechnology Biosimilars for the Management of Inflammatory Bowel Diseases: Economic Considerations
Current Medicinal Chemistry